Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.

Durell, Todd M

Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. [electronic resource] - Journal of clinical psychopharmacology Feb 2013 - 45-54 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1533-712X

10.1097/JCP.0b013e31827d8a23 doi


Adolescent
Adrenergic Uptake Inhibitors--adverse effects
Adult
Analysis of Variance
Atomoxetine Hydrochloride
Attention--drug effects
Attention Deficit Disorder with Hyperactivity--diagnosis
Double-Blind Method
Executive Function--drug effects
Humans
Least-Squares Analysis
Predictive Value of Tests
Propylamines--adverse effects
Prospective Studies
Psychiatric Status Rating Scales
Puerto Rico
Quality of Life
Recovery of Function
Severity of Illness Index
Time Factors
Treatment Outcome
United States
Young Adult